The penetration of cefonicid and cefazolin into cardiac tissue was compared after a single 30-mg/kg dose in 30 patients undergoing aortocoronary artery bypass graft surgery. Samples of the right atrial appendage, pericardial fluid, and serum were obtained at various times and assayed for drug content. The concentrations of cefonicid in serum and the atrial appendage were at least twice those observed for cefazolin at a given time after a dose. The mean (± standard deviation) atrial appendage-serum ratio was 0.47 ± 0.14 for cefonicid and 0.34 ± 0.06 for cefazolin (P < 0.005). Pericardial Cefonicid is a new cephalosporin with an antimicrobial spectrum similar to that of cefamandole except that it is less active against S. aureus and S. epidermidis. Cefonicid is excreted slowly by the kidneys, with a serum elimination half-life of ca. 4 h. High binding to serum proteins (96 to 98%) results in high concentrations in serum but also reduced the in vitro activity of this agent (6, 7). The high and prolonged concentrations in serum achieved after a single dose may allow for single-dose prophylaxis of infection during certain surgical procedures. In view of the pharmacokinetic properties of cefonicid and the potential usefulness of this agent in surgical prophylaxis, we compared the concentrations of cefonicid and cefazolin in serum, the right atrial appendage, and pericardial fluid of patients undergoing coronary artery bypass graft surgery.
The penetration of cefonicid and cefazolin into cardiac tissue was compared after a single 30-mg/kg dose in 30 patients undergoing aortocoronary artery bypass graft surgery. Samples of the right atrial appendage, pericardial fluid, and serum were obtained at various times and assayed for drug content. The concentrations of cefonicid in serum and the atrial appendage were at least twice those observed for cefazolin at a given time after a dose. The mean (± standard deviation) atrial appendage-serum ratio was 0.47 ± 0.14 for cefonicid and 0.34 ± 0.06 for cefazolin (P < 0.005). Pericardial fluid concentrations of cefonicid were slightly lower than those observed in patients receiving cefazolin (P > 0.05). A single intravenous dose of cefonicid provides high and sustained concentrations in serum and cardiac tissue and thus may be useful in antibiotic prophylaxis of certain surgical procedures; however, further study of the efficacy of this agent in the prevention and treatment of infections associated with Staphylococcus spp. is needed.
Short-course therapy with an antimicrobial active agent against Staphylococcus aureus and Staphylococcus epidermidis has been recommended in open-heart surgery, particularly in procedures including placement of a prosthetic valve (5, 9, 10) . Clindamycin, methicillin, vancomycin, and various cephalosporins have been considered as useful agents in this setting.
Cefonicid is a new cephalosporin with an antimicrobial spectrum similar to that of cefamandole except that it is less active against S. aureus and S. epidermidis. Cefonicid is excreted slowly by the kidneys, with a serum elimination half-life of ca. 4 h. High binding to serum proteins (96 to 98%) results in high concentrations in serum but also reduced the in vitro activity of this agent (6, 7) . The high and prolonged concentrations in serum achieved after a single dose may allow for single-dose prophylaxis of infection during certain surgical procedures. In view of the pharmacokinetic properties of cefonicid and the potential usefulness of this agent in surgical prophylaxis, we compared the concentrations of cefonicid and cefazolin in serum, the right atrial appendage, and pericardial fluid of patients undergoing coronary artery bypass graft surgery.
( the following were excluded from entry: total body weight (TBW) greater than lean body weight, +/-40%; renal dysfunction (serum creatinine greater than 1.5 mg/dl); history of a significant hypersensitivity reaction to a betalactam antibiotic; requirement for circulatory support (i.e., use of an intro-aortic balloon pump); or inability or refusal to give informed consent. There were two women in the cefonicid group and three women in the cefazolin group. The mean (+ standard deviation) total and ideal weights in the cefonicid group were 70 ± 11 and 66 ± 9 kg, respectively; in the cefazolin group, these weights were 75 ± 10 and 85 ± 10 kg, respectively. The mean preoperative serum creatinine was 1.0 ± 0.2 in the cefonicid group and 1.1 ± 0.2 in the cefazolin group. Each patient underwent a prestudy physical examination, gave a complete medical history, and had the following laboratory tests performed: complete blood count, blood urea nitrogen, serum creatinine, serum bilirubin, serum glutamic-oxaloacetic transaminase, and urinalysis. All of these tests were within the normal range in all patients.
Dosing and sample collection. Patients were randomly distributed so as to receive a single 30-mg/kg TBW dose of either cefonicid or cefazolin intravenously over 5 min before surgery. Additional antimicrobial agents were withheld until after the collection of serum and tissue samples. One to three serum samples were collected from each patient during surgery before cardiopulmonary bypass. Blood samples were centrifuged at 3,250 x g for 10 min, and the serum was harvested. Pericardial fluid was collected by aspiration through a rubber catheter after the opening of the pericardial sac. The right atrial appendage samples were obtained before right-atrial cannulation for cardiopulmonary bypass. After collection, samples of the atrial appendage were frozen in liquid nitrogen. Pericardial fluid, serum, and atrial appendage samples were stored at -80°C for 1 to 10 weeks until assay. The stability of samples was confirmed by assay of selected tissue and serum samples immediately after collection and again after storage at the above conditions.
Assay. Samples of the atrial appendage were minced and weighed, and Sorenson buffer (0.02 M, pH 5.3) was added in ANTIMICROB. AGENTS CHEMOTHER. 400 ,lI of fluid, 50% pooled human serum-509% water; for serum internal standard and then with 2 ml of acetonitrile to samples, pooled human serum. Drug concentrations in the precipitate proteins. This mixture was vortexed for 1 min pericardial fluid and atrial appendage were corrected for and centrifuged at 10,000 rpm for 10 min. The supernatant blood contamination by the method of Lowry and Hastings was decanted, mixed with 1.5 ml of dichloromethane, invert- (12) . ed gently three times, and centrifuged for 5 min at 4,000 rpm, Statistics. Atrial appendage-serum concentration ratios and the resultant aqueous layer was retained. The dichloroand pericardial fluid concentrations of cefonicid and cefazomethane wash was repeated once, and the resultant supernalin were compared by a two-tailed Mann-Whitney U test. tant was used for assay.
RESULTS
The drug contents of serum, pericardial fluid, and atrial appendage were measured by high-pressure liquid chromaThere were no differences in age, sex, TBW, lean body tography with a model WISP automatic injector, a 6000A weight, or preoperative serum creatinine concentration besolvent delivery system, and a fixed wavelength (254 nM) tween patients receiving cefonicid and those receiving cefadetector (Waters Associates, Milford, Mass.). The cefonicid concentrations exceeded 100 ,ug/ml, whereas those for cefazolin were ca. 50 ,ug/ml.
High atrial appendage concentrations of cefonicid and cefazolin were reached rapidly, within 1 h after a dose. Cefonicid concentrations in the atrial appendage at 1 and 3 h after an intravenous dose were ca. 90 and 50 ,ug/ml, respectively; these concentrations were approximately twice those observed in samples obtained at these times from patients receiving cefazolin. The mean (± standard deviation) atrial appendage-serum concentration ratio in patients receiving cefonicid was 0.47 ± 0.14, whereas it was 0.34 ± 0.06 in patients who received cefazolin (P < 0.005). The decline in tissue concentrations with time paralleled the decline in serum concentrations.
Peak concentrations of both drugs in pericardial fluid were attained within 1 and 2.5 h after the dose. Pericardial fluidserum concentration ratios ranged widely (0.03 to 0.67 and 0.05 to 0.65 for cefonicid and cefazolin, respectively) because of the slow drug distribution into the fluid. Concentrations of cefazolin in pericardial fluid at 0 to 70, 70 to 139, and 140 to 230 min after a dose tended to be higher than those observed in patients receiving cefonicid, but this difference was not statistically significant (P > 0.05) DISCUSSION It has been suggested that antibiotic prophylaxis should be timed to provide high concentrations of an agent in tissues transversed during surgery. In open-heart surgery, high concentrations of an antimicrobial agent in heart tissue may be particularly useful during the insertion of a prosthetic valve; one study reported 71% of cultures obtained from the exposed area of the heart or prosthetic valve at surgical closure were positive (11) . There are some animal and human studies available to support the need of appropriate timing of antimicrobial prophylaxis to obtain optimum serum and tissue concentrations. Studies by Burke (3) and by Alexander and Altemeier (1) demonstrated that prevention of surgical wound infections in animals occurred only when antibiotics were administered before or near the time of introduction of bacteria into the wound. Goldmann et al. reported that of 11 patients with no detectable cephalothin concentrations in serum (and presumably tissue) at the conclusion of open-heart surgery, wound infections occurred in 3; in contrast, only 2 of 175 patients with detectable cephalothin concentrations developed infections (8) . Indeed, a few small studies of antibiotic prophylaxis in open-heart surgery have shown a short perioperative course of antibiotic prophylaxis to be as effective as longer courses, thus supporting the concepts advanced by Burke and by Alexander and Altemeier (4, 8) .
High concentrations of cefonicid in serum were observed in our patients after a single 30-mg/kg dose; these concentrations were similar to those observed in normal volunteers after comparable doses (13; M. N. Dudley, W. C. Shyu, C. H. Nightingale, and R. Quintiliani, Clin. Pharmacol. Ther. 35:236, 1984) . Concentrations of both drugs in the atrial appendage peaked rapidly and declined in parallel with concentrations in serum; this is consistent with previous observations of the distribution and elimination of cephalosporins in the atrial appendage (14) . Concentrations of cefonicid in the atrial appendage were significantly greater than those of cefozolin observed in the present study, as well as those observed with the available cephalosporins studied at our institution (14) . Cefonicid appeared to penetrate the atrial appendage much more effectively than did cefazolin; the average atrial appendage-serum concentration ratio for cefonicid was significantly greater than that observed for cefazolin. Cefazolin concentrations and penetration ratios in the atrial appendage were similar to those previously reported (14) .
Cefonicid concentrations in the atrial appendage and penetration ratios were markedly higher in our study than those recently reported by Sterling et al. after a comparable 2-g dose (15) . However, there are a few differences in study design that account for these differences. Sterling et al. used the intramuscular route of administration, whereas we used a bolus intravenous infection. Previous studies have shown that bolus administration produces higher concentrations in tissues than does continuous infusion (which is somewhat analogous to an intramuscular injection) (2). In addition, Sterling et al. prepared cefonicid standards for a microbiological assay of atrial appendage samples in phosphate buffer. Since their method did not precipitate proteins during the tissue extraction procedure, their assay would tend to underestimate tissue concentrations.
Peak concentrations in pericardial fluid were delayed, reflecting slow distribution of these drugs into this extravascular fluid. Previous studies in animals demonstrated that the penetration of antibiotics into uninfected pericardial fluid was inversely proportional to the extent of plasma protein binding (16) . Consistent with these observations, cefazolin (85% bound) concentrations in pericardial fluid tended to be higher than those observed for cefonicid (98% bound); however, this difference was not statistically significant.
In summary, a single 30-mg/kg intravenous dose of cefonicid produced high and prolonged concentrations in serum, pericardial fluid, and heart tissue. Its pharmacokinetic properties make cefonicid a suitable agent for single-dose prophylaxis of certain surgical procedures. However, these properties may be negated by its poor in vitro activity against Staphylococcus spp; cefonicid is 4 to 16 times less active in vitro than cefazolin (6) . Clinical studies have shown a single dose to be effective in the prophylaxis of infection in certain surgical procedures; presently, cefonicid has received only limited study of its effectiveness in open-heart surgery (7). In view of the poor activity of this agent against S. aureus and S. epidermidis, further study correlating high tissue concentrations with efficacy in open-heart surgery is needed.
